COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management
- PMID: 33664170
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management
Abstract
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic. COVID-19 pandemic has overburdened healthcare systems in most countries and has led to massive economic losses. SARS-CoV-2 transmission typically occurs by respiratory droplets. The average incubation period is 6.4 days and presenting symptoms typically include fever, cough, dyspnea, myalgia or fatigue. While the majority of patients tend to have a mild illness, a minority of patients develop severe hypoxia requiring hospitalization and mechanical ventilation. Management is mostly supportive. However, several direct anti-viral agents, and immunomodulatory therapy with steroids and various cytokine blockers seem promising in early results. However, an effective vaccine has been established, which will help curb the pandemic.
Similar articles
-
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.Curr Mol Med. 2021;21(7):562-572. doi: 10.2174/1566524020666201203170230. Curr Mol Med. 2021. PMID: 33272178 Review.
-
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2. AAPS J. 2021. PMID: 33400058 Free PMC article. Review.
-
Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.Crit Rev Eukaryot Gene Expr. 2021;31(3):21-34. doi: 10.1615/CritRevEukaryotGeneExpr.2021038075. Crit Rev Eukaryot Gene Expr. 2021. PMID: 34369712 Review.
-
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19).Indian J Tuberc. 2021 Jan;68(1):92-98. doi: 10.1016/j.ijtb.2020.09.021. Epub 2020 Sep 28. Indian J Tuberc. 2021. PMID: 33641858 Free PMC article. Review.
-
The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.Genet Test Mol Biomarkers. 2021 Feb;25(2):85-101. doi: 10.1089/gtmb.2020.0227. Genet Test Mol Biomarkers. 2021. PMID: 33596144 Review.
Cited by
-
Lectin Analysis of SARS-CoV-2-Positive Nasopharyngeal Samples Using GLYcoPROFILE® Technology Platform.Diagnostics (Basel). 2022 Nov 18;12(11):2860. doi: 10.3390/diagnostics12112860. Diagnostics (Basel). 2022. PMID: 36428920 Free PMC article.
-
Paucisymptomatic post COVID-19 myocarditis in a young athlete during return to play workflow: possible usefulness of global longitudinal strain analysis.BMJ Case Rep. 2024 Jan 12;17(1):e255863. doi: 10.1136/bcr-2023-255863. BMJ Case Rep. 2024. PMID: 38216160 Free PMC article.
-
Personalized pulmonary rehabilitation program for patients with post-acute sequelae of COVID-19: A proof-of-concept retrospective study.Physiol Rep. 2024 Feb;12(3):e15931. doi: 10.14814/phy2.15931. Physiol Rep. 2024. PMID: 38296347 Free PMC article.
-
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study.Infez Med. 2023 Mar 1;31(1):49-54. doi: 10.53854/liim-3101-7. eCollection 2022. Infez Med. 2023. PMID: 36908386 Free PMC article.
-
Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordance.Front Immunol. 2023 Jan 20;13:1052424. doi: 10.3389/fimmu.2022.1052424. eCollection 2022. Front Immunol. 2023. PMID: 36741379 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous